Syngenta and Aphea.Bio collaborate to bring novel wheat biostimulant to European markets

A new collaboration between Syngenta Crop Protection and Aphea.Bio is set to bring a novel agricultural technology to European markets. The partnership aims to accelerate the introduction of biological seed treatments to multiple European countries over the next five years, pending regulatory approval. 

″We are excited to announce this collaboration with Aphea.Bio, which supports our important ambition of helping feed ever-growing populations in more sustainable ways,″ said Jonathan Brown, head of global seedcare at Syngenta Crop Protection, in a news release. ″It demonstrates our commitment to bringing novel, nutrient use efficiency solutions to growers, helping safeguard yields if nitrogen inputs are reduced. Combined with our leading conventional seed treatment portfolio, ACTIV by Aphea.Bio will offer a unique value proposition in a fast-changing EU landscape.″

A biostimulant applied as a seed treatment on wheat, ACTIV by Aphea.Bio is based on beneficial microorganisms. ACTIV can improve yields by as much as 5% by improving the crop’s nutrient efficiency. 

The release of ACTIV will provide European farmers with much-needed technology, and while addressing challenges rising from an increasingly constrained toolbox of available technologies and evolving consumer demands. 

″We are excited to launch our first wheat biostimulant in partnership with Syngenta,″ said Isabel Vercauteren, CEO and co-founder of Aphea.Bio, in a news release. ″We are joining forces to build a more sustainable and profitable future for European farmers. And this is just the beginning.″